These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15120960)

  • 1. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins.
    Hu T; Gibson DP; Carr GJ; Torontali SM; Tiesman JP; Chaney JG; Aardema MJ
    Mutat Res; 2004 May; 549(1-2):5-27. PubMed ID: 15120960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling.
    Le Fevre AC; Boitier E; Marchandeau JP; Sarasin A; Thybaud V
    Mutat Res; 2007 Jun; 619(1-2):16-29. PubMed ID: 17374387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gene expression changes induced in mouse and human cells treated with direct-acting mutagens.
    Islaih M; Li B; Kadura IA; Reid-Hubbard JL; Deahl JT; Altizer JL; Watson DE; Newton RK
    Environ Mol Mutagen; 2004; 44(5):401-19. PubMed ID: 15515172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
    Sakai R; Kondo C; Oka H; Miyajima H; Kubo K; Uehara T
    Toxicology; 2014 Jan; 315():8-16. PubMed ID: 24211769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea.
    Müller A; Boitier E; Hu T; Carr GJ; Le Fèvre AC; Marchandeau JP; Flor M; Jefferson F; Aardema MJ; Thybaud V
    Environ Mol Mutagen; 2005 Dec; 46(4):221-35. PubMed ID: 16127667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells.
    Magkoufopoulou C; Claessen SM; Jennen DG; Kleinjans JC; van Delft JH
    Mutagenesis; 2011 Sep; 26(5):593-604. PubMed ID: 21632981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transcriptome profiles for the DNA-damaging agents bleomycin and hydrogen peroxide in L5178Y mouse lymphoma cells.
    Seidel SD; Kan HL; Stott WT; Schisler MR; Gollapudi BB
    Environ Mol Mutagen; 2003; 42(1):19-25. PubMed ID: 12874809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating mechanisms of toxicity using global gene expression analysis in Saccharomyces cerevisiae.
    Caba E; Dickinson DA; Warnes GR; Aubrecht J
    Mutat Res; 2005 Aug; 575(1-2):34-46. PubMed ID: 15878181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium bromate treatment predominantly causes large deletions, but not GC>TA transversion in human cells.
    Luan Y; Suzuki T; Palanisamy R; Takashima Y; Sakamoto H; Sakuraba M; Koizumi T; Saito M; Matsufuji H; Yamagata K; Yamaguchi T; Hayashi M; Honma M
    Mutat Res; 2007 Jun; 619(1-2):113-23. PubMed ID: 17428505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells.
    Schreck I; Chudziak D; Schneider S; Seidel A; Platt KL; Oesch F; Weiss C
    Toxicology; 2009 May; 259(3):91-6. PubMed ID: 19428948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking genotoxic responses with cytotoxic and behavioural or physiological consequences: differential sensitivity of echinoderms (Asterias rubens) and marine molluscs (Mytilus edulis).
    Canty MN; Hutchinson TH; Brown RJ; Jones MB; Jha AN
    Aquat Toxicol; 2009 Aug; 94(1):68-76. PubMed ID: 19564054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
    Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
    Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolites.
    Pandey AK; Gurbani D; Bajpayee M; Parmar D; Ajmani S; Dhawan A
    Mutat Res; 2009 Feb; 661(1-2):57-70. PubMed ID: 19059273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay.
    Hu T; Kaluzhny Y; Mun GC; Barnett B; Karetsky V; Wilt N; Klausner M; Curren RD; Aardema MJ
    Mutat Res; 2009 Mar; 673(2):100-8. PubMed ID: 19167513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds.
    Mathijs K; Brauers KJ; Jennen DG; Lizarraga D; Kleinjans JC; van Delft JH
    Mutagenesis; 2010 Nov; 25(6):561-8. PubMed ID: 20650930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/- mouse lymphoma cells.
    Kellert M; Brink A; Richter I; Schlatter J; Lutz WK
    Mutat Res; 2008 Dec; 657(2):127-32. PubMed ID: 18804178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.